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In Gram-negative bacteria, envelope stress signals such as unfolded outer membrane 
proteins (OMP) activate the periplasmic protease DegS. This protease then triggers a cellular 
pathway to alleviate the stress. Now Sohn et al. (2007) show conclusively that inhibition of 
DegS is relieved allosterically by binding of the C-terminal sequences in unfolded OMPs to 
the PDZ domain of DegS.The envelope of Gram-negative 
bacteria consists of the inner cyto-
plasmic membrane, the outer mem-
brane, and the periplasmic space in 
between. Survival of these bacteria 
depends on the integrity of the enve-
lope. The Gram-negative bacterium 
Escherichia coli has developed 
elaborate mechanisms to moni-
tor and respond to specific forms 
of periplasmic stress signals (Alba 
and Gross, 2004; Ruiz and Silhavy, 
2005). In response to accumula-
tion of unfolded or misfolded outer 
membrane proteins (OMPs) in the periplasm, a cascade of controlled 
proteolysis ensues, culminating 
in the transcriptional activation of 
genes that encode chaperones and 
proteases destined for the periplasm 
(Figure 1). In this issue, Sohn et al. 
(2007) report the mechanism of acti-
vation of the serine protease DegS, 
the sensor and first essential com-
ponent of the OMP stress response.
DegS has a C-terminal PDZ domain 
that is exposed to the periplasm and 
an N-terminal transmembrane region 
that anchors DegS to the cytoplasmic 
membrane (Figure 1). DegS is acti-Cell 131, Novated by unfolded OMPs and specifi-
cally cleaves the periplasmic domain 
of a transmembrane protein RseA. 
The cytoplasmic domain of RseA 
sequesters the transcription factor σE. 
DegS-mediated proteolysis is a pre-
requisite for the subsequent cleavage 
of the transmembrane segment of 
RseA by the intramembrane metallo-
protease YaeL (also known as RseP). 
The second cleavage results in the 
release of the membrane-anchored 
RseA-σE complex into the cytoplasm. 
The final steps of signaling involve 
selective degradation of RseA by Figure 1. A Bacterial Stress Response Mediated by DegS
In the absence of stress signals from unfolded outer membrane proteins (OMPs), DegS remains inactive due to intramolecular inhibition from the 
PDZ domain. (1) The C-terminal sequences of unfolded OMPs bind to the PDZ domains, relieving inhibition of DegS. (2) Activated DegS cleaves 
RseA between Val148 and Ser149 in the periplasm. (3) The membrane-embedded metalloprotease YaeL cleaves the transmembrane segment of 
RseA, which releases the N-terminal fragment of RseA into the cytoplasm. (4) The N-terminal fragment of RseA is degraded by cellular proteases 
(Chaba et al., 2007). (5) The released transcription factor σE binds to RNA polymerase, activating transcription.vember 2, 2007 ©2007 Elsevier Inc. 441
cytoplasmic proteases, releasing σE 
to interact with RNA polymerase and 
enhance gene transcription.
Recent investigations have mark-
edly improved our understanding of 
the molecular underpinnings of the 
OMP stress response. For example, 
the C-terminal Tyr-X-Phe (YXF, where 
X is any amino acid) sequences of 
OMP were shown to bind directly to 
the PDZ domain of DegS, which trig-
gers the activation of DegS and cleav-
age of RseA (Walsh et al., 2003). How-
ever, how binding of the PDZ domain 
by the OMP peptides results in DegS 
activation is still under debate.
Compared to wild-type DegS, the 
DegS mutant lacking the PDZ domain 
exhibited lower expression levels yet 
displayed markedly higher σE activity 
in E. coli, suggesting increased pro-
tease activity (Walsh et al., 2003) and 
a negative regulatory role for the PDZ 
domain. Supporting this notion, pep-
tides with C-terminal OMP sequences 
were shown to directly bind to the PDZ 
domain of DegS in vitro and induced 
σE activity in cells (Walsh et al., 2003). 
These experiments suggest an allos-
teric model, in which binding of the 
OMP peptides to the PDZ domain 
relieves its inhibition of the protease 
domain.
The allosteric model was consistent 
with most of the experimental evi-
dence. For example, the crystal struc-
ture of the ligand-free DegS revealed 
an unproductive active site conforma-
tion (Wilken et al., 2004; Zeth, 2004). 
Binding of a decapeptide ending with 
the Tyr-Gln-Phe (YQF) sequence to 
the PDZ domain caused major con-
formational changes in the protease 
domain. Interestingly, the penultimate 
residue glutamine (Gln) donates a 
hydrogen bond to a main chain car-
bonyl group in the protease domain; 
this interaction was thought to pull a 
flexible L3 loop by 15 Å resulting in 
the formation of a productive confor-
mation at the active site (Wilken et al., 
2004). On the basis of this observa-
tion, Wilken and colleagues proposed 
a “scaffold model” in which binding of 
the YQF motif by the PDZ domain was 
thought to orient the penultimate resi-
due for interactions with residues in 
the protease domain, and such inter-442 Cell 131, November 2, 2007 ©2007 Eactions were consequently responsi-
ble for the activation of DegS (Wilken 
et al., 2004). The scaffold model and 
the allosteric model are different and 
give rise to predictions that can be 
readily tested by experiments.
In their new work, Sohn et al. 
(2007) present a combination of bio-
chemical and structural experiments 
that strongly support the allosteric 
model. Evaluation of the two compet-
ing models requires a sensitive pro-
tease assay for DegS. However, the 
previously reported DegS protease 
assays, involving incubation times of 
as much as 12 hr, were inadequate 
for determination of kinetic param-
eters that can definitively differenti-
ate these two models. Optimization 
of the assay conditions shortened the 
time of cleavage reaction from hours 
to minutes (Sohn et al., 2007). For the 
first time, the measured turnover rate 
of RseA cleavage by DegS in vitro 
was fast enough to account for the 
precipitous drop in intracellular RseA 
levels within minutes of OMP stress 
signaling. Importantly, under these 
conditions, initial rates of cleavage 
were linearly proportional to concen-
trations of DegS.
Steady-state kinetic parameters 
were found to be similar for DegS 
bound to OMP peptides and for a 
DegS variant lacking the PDZ domain 
(Sohn et al., 2007). These observa-
tions demonstrate that neither PDZ 
nor the OMP peptide is required for 
efficient cleavage of RseA in vitro. 
This analysis supports the allosteric 
model and is inconsistent with the 
scaffold model, as the latter would 
predict a markedly lower turnover rate 
for the PDZ-deleted DegS variant. A 
direct test of the scaffold model is to 
assess the impact of the penultimate 
residue of OMP peptides on DegS 
protease activity. Compared to Gln 
or Tyr, placement of small and nega-
tively charged amino acids, such as 
Ala and Asp, in the penultimate posi-
tion in OMP peptides had little impact 
on the maximum cleavage activity of 
DegS (Sohn et al., 2007). The concen-
trations of the various OMP peptides 
required for half-maximal activity of 
DegS correlated with their binding 
affinities. These data strongly argue lsevier Inc.against a critical role for the identity 
of the penultimate residue in OMP 
peptides as proposed by the scaf-
fold model (Wilken et al., 2004). Cor-
roborating the biochemical analyses, 
structures of the PDZ-deleted DegS 
variants revealed an active site that 
more closely resembles the produc-
tive conformation (Sohn et al., 2007).
These biochemical and structural 
data lend conclusive support to the 
allosteric model of DegS activation. 
The key question then becomes: What 
about the reported evidence that was 
thought to support the scaffold model? 
The experimental observation that gave 
rise to the scaffold model is a hydro-
gen bond between the penultimate Gln 
residue of the OMP peptide and a main 
chain group in the protease domain of 
DegS (Wilken et al., 2004). However, 
the anticipated interaction between 
the antepenultimate Tyr residue of the 
OMP peptide YXF and the PDZ domain 
of DegS was not observed in the crys-
tal structure (Wilken et al., 2004). This 
observation contrasts sharply with the 
important role of the antepenultimate 
Tyr residue in OMP peptides (Walsh et 
al., 2003) and begs for cautious inter-
pretation of any role for the penultimate 
residue Gln. After all, the YQF peptide 
was far less able to activate DegS com-
pared to OMP peptides with hydro-
phobic amino acids in the penultimate 
position (Walsh et al., 2003; Wilken et 
al., 2004).
The new study reveals additional 
mechanistic insights into DegS activ-
ity. Analysis of the Michaelis-Menten 
plot revealed a Hill constant indicative 
of cooperative RseA binding and cleav-
age by the DegS trimer (Sohn et al., 
2007). The Hill constants were similar 
for the intact DegS and PDZ-deleted 
DegS, suggesting that allostery from 
binding by OMP peptides is not respon-
sible for the cooperativity of substrate 
cleavage. Additional analysis using an 
altered substrate, which slowed down 
cleavage, supports the hypothesis that 
the cooperativity may be derived from 
interactions among the RseA substrate 
molecules (Sohn et al., 2007).
PDZ-mediated inhibition of DegS 
protease activity obviously depends 
on the interactions between PDZ and 
the protease domains. But which 
interactions and what amino acids? 
Mutagenesis of amino acids at the 
interface between PDZ and the pro-
tease domains revealed some tantaliz-
ing clues. Three amino acids (Lys243, 
Arg256, and Asp320) in the PDZ domain 
were found to be particularly impor-
tant, as their mutation led to drastically 
increased basal rate cleavage of RseA 
(Sohn et al., 2007). In addition, Arg178 
in the protease domain, which is highly 
conserved among DegS orthologs, 
was thought to be the key determinant 
in the allosteric switch from the inactive 
to active conformation.
These latest advances contribute 
to an improved model (Figure 1) and 
make quantitative understanding of 
the OMP stress response possible. 
For example, the moderate binding 
affinities between the OMP peptides 
and DegS likely ensure a threshold for 
detection of the stress response: only 
when there is an accumulation of the 
unfolded OMP proteins. In addition, 
the wide range of binding affinities for 
DegS—4.6 µM for the YYF sequence 
and 130 µM for the YAF sequence 
(Sohn et al., 2007)—may set a differ-Vascular endothelial growth factor 
(VEGF) plays an indispensable role 
in the formation of new blood ves-
sels in both physiological and path-
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tissues—whether used alone
change the way we treat cance
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family, has such potential in ment threshold for the accumulation of 
differing OMP proteins. It should be 
noted, however, that many unanswered 
questions remain. RseB, a periplasmic 
protein that binds to RseA, was shown 
to inhibit DegS-mediated cleavage of 
RseA in vitro regardless of the OMP 
peptides (Cezairliyan and Sauer, 2007). 
The molecular basis for this inhibition 
remains to be investigated. How DegS 
overcomes RseB-mediated inhibi-
tion of RseA during the OMP stress 
response remains unclear. Periplasmic 
proteolysis of RseA by DegS is merely 
a prerequisite for the second cleavage 
of RseA by the membrane-embedded 
metalloprotease YaeL—why this is the 
case remains unknown.
DegS is a representative member 
of a family of PDZ-containing serine 
proteases (Clausen et al., 2002). Does 
the allosteric mechanism observed 
for DegS apply to other family mem-
bers? After all, these proteases share 
conserved domain structures and 
sequences and form trimers in solu-
tion. Similar to DegS, deletion of the 
PDZ domain makes human HtrA2 (a 
DegS homolog) more active (Li et al., Cell 131, No
ological settings. The anti-VEGF 
monoclonal antibody bevacizumab 
(referred to henceforth as αVEGF), 
when used as the sole therapy in 
Kid on the 
sis Block
 of Radiation Oncology, Massachusetts Gen
d.edu
giogenesis, growth, and metas
 or in combination with curre
r. In this issue, Fischer et al. (20
ainst placental growth factor (
ice.2002). Therefore, it is tempting to spec-
ulate that the mechanism of activation 
described by Sohn et al. might be gen-
erally applicable to other members of 
this family of proteases.
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